Page last updated: 2024-09-04

cinacalcet and nps-568

cinacalcet has been researched along with nps-568 in 23 studies

Compound Research Comparison

Studies (cinacalcet)	Trials (cinacalcet)	Recent Studies (post-2010) (cinacalcet)	Studies (nps-568)	Trials (nps-568)	Recent Studies (post-2010) (nps-568)
1,070	155	627	162	4	54
1,070	155	627	15	0	10

Research

Studies (23)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	18 (78.26)	29.6817
2010's	4 (17.39)	24.3611
2020's	1 (4.35)	2.80

Authors

Authors	Studies
Cohen, A; Silverberg, SJ	1
Goodman, WG	2
Hoppe, A; Rybczyńska, A	1
Nemeth, EF	1
Drüeke, TB	1
Franceschini, N; Joy, MS; Kshirsagar, AV	1
Nagano, N; Nemeth, EF	1
Lindberg, JS	1
Nagano, N	2
Chudek, J; Piecha, G; Wiecek, A	1
Cunningham, J	1
de Vernejoul, MC; Legoupil, N; Ureña, P	1
Craig, JC; Elder, G; Messa, P; Palmer, S; Strippoli, GF; Tong, A	1
Akizawa, T; Kinugasa, E; Koiwa, F; Ogata, H	1
Fotsch, C; Harrington, PE	1
Al-Aly, Z	1
Christopoulos, A; Conigrave, AD; Davey, AE; Leach, K; Sexton, PM; Valant, C	1
Christopoulos, A; Conigrave, AD; Cook, AE; Furness, SG; Gregory, KJ; Leach, K; Mistry, SN; Scammells, PJ; Sexton, PM	1
Christopoulos, A; Conigrave, AD; Diao, J; Gregory, KJ; Josephs, TM; Keller, AN; Kufareva, I; Leach, K; Mai, VT	1
Hao, Y; Ji, W; Lei, Z; Shi, N; Yu, L; Zhang, X	1
Auberval, M; Deprez, P; Guédin, D; Jary, H; Lively, S; Temal, T; Vevert, JP	1

Reviews

17 review(s) available for cinacalcet and nps-568

Article	Year
Calcimimetics: therapeutic potential in hyperparathyroidism. Current opinion in pharmacology, 2002, Volume: 2, Issue:6 Topics: Aniline Compounds; Calcium; Cinacalcet; Homeostasis; Humans; Hyperparathyroidism; Molecular Mimicry; Naphthalenes; Phenethylamines; Propylamines; Receptors, Calcium-Sensing; Receptors, Cell Surface	2002
Calcimimetic agents and secondary hyperparathyroidism: rationale for use and results from clinical trials. Pediatric nephrology (Berlin, Germany), 2003, Volume: 18, Issue:12 Topics: Aniline Compounds; Child; Cinacalcet; Clinical Trials as Topic; Humans; Hyperparathyroidism, Secondary; Naphthalenes; Parathyroid Hormone; Phenethylamines; Propylamines; Receptors, Calcium-Sensing	2003
[Calcimimmetic and calcilytics: new perspectives of correction of abnormal parathormone (PTH) secretion]. Przeglad lekarski, 2003, Volume: 60, Issue:6 Topics: Aniline Compounds; Calcium; Calcium Channel Blockers; Cinacalcet; Humans; Hyperparathyroidism; Naphthalenes; Phenethylamines; Propylamines	2003
Calcimimetic and calcilytic drugs: just for parathyroid cells? Cell calcium, 2004, Volume: 35, Issue:3 Topics: Aniline Compounds; Animals; Calcium; Calcium Channels; Cinacalcet; Fendiline; Humans; Hyperparathyroidism; Naphthalenes; Osteoporosis; Parathyroid Glands; Phenethylamines; Propylamines; Receptors, Calcium-Sensing; Stereoisomerism	2004
Calcimimetics and the treatment of primary and secondary hyperparathyroidism. The Annals of pharmacotherapy, 2004, Volume: 38, Issue:11 Topics: Aniline Compounds; Animals; Cinacalcet; Half-Life; Humans; Hyperparathyroidism, Secondary; Metabolic Clearance Rate; Naphthalenes; Phenethylamines; Propylamines; Randomized Controlled Trials as Topic; Rats	2004
Calcimimetic agents for the treatment of secondary hyperparathyroidism. Seminars in nephrology, 2004, Volume: 24, Issue:5 Topics: Aniline Compounds; Cinacalcet; Clinical Trials as Topic; Humans; Hyperparathyroidism, Secondary; Naphthalenes; Phenethylamines; Propylamines	2004
Functional proteins involved in regulation of intracellular Ca(2+) for drug development: the extracellular calcium receptor and an innovative medical approach to control secondary hyperparathyroidism by calcimimetics. Journal of pharmacological sciences, 2005, Volume: 97, Issue:3 Topics: Aniline Compounds; Animals; Calcium; Cinacalcet; Clinical Trials as Topic; Drug Design; Drug Evaluation, Preclinical; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Models, Biological; Molecular Structure; Naphthalenes; Parathyroid Glands; Parathyroid Hormone; Phenethylamines; Propylamines; Rats; Receptors, Calcium-Sensing	2005
Calcimimetics: a new tool for management of hyperparathyroidism and renal osteodystrophy in patients with chronic kidney disease. Kidney international. Supplement, 2005, Issue:95 Topics: Aniline Compounds; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Humans; Hyperparathyroidism; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Phenethylamines; Propylamines; Vitamin D	2005
Pharmacological and clinical properties of calcimimetics: calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism. Pharmacology & therapeutics, 2006, Volume: 109, Issue:3 Topics: Aniline Compounds; Animals; Calcium; Cinacalcet; Humans; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Naphthalenes; Parathyroid Hormone; Phenethylamines; Propylamines; Receptors, Calcium-Sensing	2006
[Calcimimetics--a new treatment for hyperparathyroidism?]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2005, Volume: 18, Issue:107 Topics: Allosteric Site; Aniline Compounds; Animals; Calcium; Calcium-Binding Proteins; Cinacalcet; Humans; Hyperparathyroidism; Naphthalenes; Parathyroid Hormone; Phenethylamines; Propylamines; Receptors, Calcium-Sensing; Treatment Outcome	2005
[Management of secondary hyperparathyroidism]. Clinical calcium, 2005, Volume: 15 Suppl 1 Topics: Aniline Compounds; Calcinosis; Calcium; Cinacalcet; Clinical Trials as Topic; Drug Design; Drug Therapy, Combination; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Phenethylamines; Phosphorus; Polyamines; Practice Guidelines as Topic; Propylamines; Receptors, Calcium-Sensing; Sevelamer; Vascular Diseases; Vitamin D	2005
[Calcimimetics, mechanisms of action and therapeutic applications]. Presse medicale (Paris, France : 1983), 2005, Sep-10, Volume: 34, Issue:15 Topics: Aniline Compounds; Animals; Bone Remodeling; Calcium; Cells, Cultured; Cinacalcet; Double-Blind Method; Female; Humans; Hyperparathyroidism; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Hyperplasia; Male; Middle Aged; Multicenter Studies as Topic; Naphthalenes; Parathyroid Glands; Parathyroid Hormone; Parathyroid Neoplasms; Phenethylamines; Propylamines; Randomized Controlled Trials as Topic; Rats; Receptors, Calcium-Sensing; Renal Dialysis; Risk Factors; Time Factors; Uremia	2005
Meta-analysis of biochemical and patient-level effects of calcimimetic therapy. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2006, Volume: 47, Issue:5 Topics: Aniline Compounds; Calcium; Chronic Disease; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Naphthalenes; Phenethylamines; Propylamines; Randomized Controlled Trials as Topic	2006
[Calcium receptor/calcium-sensing receptor]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2006, Volume: 128, Issue:3 Topics: Aniline Compounds; Binding Sites; Calcium; Cinacalcet; Clinical Trials as Topic; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Mutation; Naphthalenes; Phenethylamines; Propylamines; Receptors, Calcium-Sensing; Signal Transduction	2006
CKD-MBD: impact on management of kidney disease. Clinical and experimental nephrology, 2007, Volume: 11, Issue:4 Topics: Aniline Compounds; Bone Diseases, Metabolic; Calcium Metabolism Disorders; Cardiovascular Diseases; Chelating Agents; Cinacalcet; Disease Progression; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Lanthanum; Naphthalenes; Phenethylamines; Polyamines; Propylamines; Renal Insufficiency, Chronic; Sevelamer; Vitamin D; Vitamin D Deficiency; Vitamins	2007
Calcium sensing receptor activators: calcimimetics. Current medicinal chemistry, 2007, Volume: 14, Issue:28 Topics: Aniline Compounds; Animals; Calcium; Cinacalcet; Humans; Models, Biological; Naphthalenes; Phenethylamines; Propylamines; Receptors, Calcium-Sensing	2007
The new role of calcimimetics as vasculotropic agents. Kidney international, 2009, Volume: 75, Issue:1 Topics: Aniline Compounds; Calcinosis; Calcium; Cardiovascular Diseases; Cinacalcet; Humans; Naphthalenes; Phenethylamines; Propylamines; Receptors, Calcium-Sensing	2009

Other Studies

6 other study(ies) available for cinacalcet and nps-568

Article	Year
Modulation and action of the calcium-sensing receptor. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2004, Volume: 19 Suppl 5 Topics: Aniline Compounds; Animals; Calcium; Cell Membrane; Cells, Cultured; Cinacalcet; Humans; Kidney; Mutation; Naphthalenes; Parathyroid Glands; Phenethylamines; Propylamines; Receptors, Calcium-Sensing	2004
Positive and negative allosteric modulators promote biased signaling at the calcium-sensing receptor. Endocrinology, 2012, Volume: 153, Issue:3 Topics: Allosteric Site; Aniline Compounds; Calcimimetic Agents; Calcium; Cell Membrane; Cinacalcet; HEK293 Cells; Humans; Hyperparathyroidism; Kidney Diseases; Kidney Failure, Chronic; Ligands; Naphthalenes; Phenethylamines; Phosphorylation; Propylamines; Receptors, Calcium-Sensing; Signal Transduction; Treatment Outcome	2012
Biased allosteric modulation at the CaS receptor engendered by structurally diverse calcimimetics. British journal of pharmacology, 2015, Volume: 172, Issue:1 Topics: Allosteric Regulation; Aniline Compounds; Calcimimetic Agents; Calcium; Cinacalcet; HEK293 Cells; Humans; Indoles; Inositol Phosphates; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Naphthalenes; Phenethylamines; Phosphorylation; Propylamines; Receptors, Calcium-Sensing	2015
Identification of Global and Ligand-Specific Calcium Sensing Receptor Activation Mechanisms. Molecular pharmacology, 2018, Volume: 93, Issue:6 Topics: Allosteric Regulation; Allosteric Site; Amino Acid Sequence; Calcium; Cell Line; Cinacalcet; Humans; Ligands; Mutagenesis, Site-Directed; Phenethylamines; Propylamines; Receptors, Calcium-Sensing; Structure-Activity Relationship	2018
Radiofrequency Ablation of Parathyroid Glands to Treat a Patient With Hypercalcemia Caused by a Novel Inactivating Mutation in Frontiers in endocrinology, 2021, Volume: 12 Topics: Adult; Calcium; Calcium-Regulating Hormones and Agents; Cinacalcet; HEK293 Cells; Humans; Hypercalcemia; Male; Mutation; Parathyroid Glands; Parathyroid Hormone; Phenethylamines; Propylamines; Radiofrequency Ablation; Receptors, Calcium-Sensing; Treatment Failure	2021
New potent calcimimetics: I. Discovery of a series of novel trisubstituted ureas. Bioorganic & medicinal chemistry letters, 2013, Apr-15, Volume: 23, Issue:8 Topics: Biomimetic Materials; Calcium; Receptors, Calcium-Sensing; Structure-Activity Relationship; Urea	2013